Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

After hours: January 13 at 4:03:01 PM EST Loading Chart for GLP ...

Global Partners LP (GLP) reports significant gains in key financial metrics and strategic expansions, despite rising expenses. WALTHAM, Mass., November 08, 2024--Global Partners LP (NYSE ...

GLP-1s have quickly gotten caught up in this black ... they may be able to spark more action toward getting started with — and staying on — new drugs and therapies that can transform the ...

“The first is to truly reframe their value proposition to position themselves as complementary to GLP-1 therapies rather than competitors,” says Depiesse. “There’s an opportunity for diet brands to ...

A new weight loss service offering GLP-1 injections has been launched. Vertis Health, based in Worcestershire, has introduced the service through its Well by Vertis programme. This comes as a response ...

A new study suggests that GLP-1 receptor agonist drugs like tirzepatide and semaglutide can significantly decrease post-surgery complications in diabetic patients. The drugs, marketed as Mounjaro and ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

In the clip, Jonathan said: "Alright, I have a confession to make. Yes, I am on a GLP-1 or a weight-loss medication. "If you have been following me for a long time, you’ll know that I gained and lost ...